Avanos Medical (NYSE:AVNS) Reaches New 12-Month Low – Here’s What Happened

Avanos Medical, Inc. (NYSE:AVNS)’s stock price hit a new 52-week low during trading on Monday . The stock traded as low as $15.10 and last traded at $15.10, with a volume of 141 shares. The stock had previously closed at $15.20.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Avanos Medical Price Performance

The company has a market capitalization of $726.12 million, a price-to-earnings ratio of 46.47 and a beta of 0.99. The firm’s 50 day moving average price is $17.70 and its two-hundred day moving average price is $20.87. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AVNS. American Century Companies Inc. increased its stake in shares of Avanos Medical by 12.1% during the 2nd quarter. American Century Companies Inc. now owns 82,930 shares of the company’s stock worth $1,652,000 after purchasing an additional 8,929 shares during the last quarter. Federated Hermes Inc. increased its stake in shares of Avanos Medical by 4.2% during the 2nd quarter. Federated Hermes Inc. now owns 97,097 shares of the company’s stock worth $1,934,000 after purchasing an additional 3,938 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Avanos Medical during the 2nd quarter worth about $202,000. Canada Pension Plan Investment Board acquired a new position in shares of Avanos Medical during the 2nd quarter worth about $70,000. Finally, Public Sector Pension Investment Board increased its stake in shares of Avanos Medical by 6.1% during the 2nd quarter. Public Sector Pension Investment Board now owns 100,957 shares of the company’s stock worth $2,011,000 after purchasing an additional 5,793 shares during the last quarter. 95.17% of the stock is currently owned by institutional investors and hedge funds.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.